Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mahir Karakas

Showing results (1-10 of 117) with videos related to

Pageof 12
Sort By:
Herz|December 22, 2009
CRP in cardiovascular diseaseMahir Karakas, Wolfgang Koenig
Current Atherosclerosis Reports|March 13, 2012
Myeloperoxidase production by macrophage and risk of atherosclerosisMahir Karakas, Wolfgang Koenig
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
Lp-PLA2 Inhibition-The Atherosclerosis Panacea?Mahir Karakas, Wolfgang Koenig
Idrugs : the Investigational Drugs Journal|August 22, 2009
Varespladib methyl, an oral phospholipase A2 inhibitor for the potential treatment of coronary artery diseaseMahir Karakas, Wolfgang Koenig
Clinical Chemistry and Laboratory Medicine|December 4, 2016
microRNAs in cardiovascular disease - clinical applicationChristian Schulte, Mahir Karakas, Tanja Zeller
Thrombosis and Haemostasis|March 9, 2012
Variability of fibrinogen measurements in post-myocardial infarction patients. Results from the AIRGENE study center AugsburgJens Baumert, Mahir Karakas, Sonja Greven, et al.
Clinical Chemistry|March 20, 2010
Reproducibility in serial C-reactive protein and interleukin-6 measurements in post-myocardial infarction patients: results from the AIRGENE studyMahir Karakas, Jens Baumert, Sonja Greven, et al.
Medicina (Kaunas, Lithuania)|August 27, 2021
Previous Catheter Ablation Predicts In-Hospital Restoration of Sinus Rhythm in Patients Presenting with Recent-Onset Atrial Fibrillation-The Retrospective HAMBURG-AF StudyBenedict Schulte-Steinberg, Muhammet Ali Aydin, Ana Theresa Moser, et al.
Clinical Chemistry|August 21, 2014
Prognostic value of midregional pro-A-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in patients with stable coronary heart disease followed over 8 yearsMahir Karakas, Andrea Jaensch, Lutz P Breitling, et al.
BMC Public Health|May 12, 2012
Prevalence and determinants of chronic kidney disease in community-dwelling elderly by various estimating equationsDietrich Rothenbacher, Jochen Klenk, Michael Denkinger, et al.
Pageof 12

Showing results (1-10 of 117) with videos related to

Sort By:
Pageof 12
Herz|December 22, 2009
CRP in cardiovascular diseaseMahir Karakas, Wolfgang Koenig
Current Atherosclerosis Reports|March 13, 2012
Myeloperoxidase production by macrophage and risk of atherosclerosisMahir Karakas, Wolfgang Koenig
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
Lp-PLA2 Inhibition-The Atherosclerosis Panacea?Mahir Karakas, Wolfgang Koenig
Idrugs : the Investigational Drugs Journal|August 22, 2009
Varespladib methyl, an oral phospholipase A2 inhibitor for the potential treatment of coronary artery diseaseMahir Karakas, Wolfgang Koenig
Clinical Chemistry and Laboratory Medicine|December 4, 2016
microRNAs in cardiovascular disease - clinical applicationChristian Schulte, Mahir Karakas, Tanja Zeller
Thrombosis and Haemostasis|March 9, 2012
Variability of fibrinogen measurements in post-myocardial infarction patients. Results from the AIRGENE study center AugsburgJens Baumert, Mahir Karakas, Sonja Greven, et al.
Clinical Chemistry|March 20, 2010
Reproducibility in serial C-reactive protein and interleukin-6 measurements in post-myocardial infarction patients: results from the AIRGENE studyMahir Karakas, Jens Baumert, Sonja Greven, et al.
Medicina (Kaunas, Lithuania)|August 27, 2021
Previous Catheter Ablation Predicts In-Hospital Restoration of Sinus Rhythm in Patients Presenting with Recent-Onset Atrial Fibrillation-The Retrospective HAMBURG-AF StudyBenedict Schulte-Steinberg, Muhammet Ali Aydin, Ana Theresa Moser, et al.
Clinical Chemistry|August 21, 2014
Prognostic value of midregional pro-A-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in patients with stable coronary heart disease followed over 8 yearsMahir Karakas, Andrea Jaensch, Lutz P Breitling, et al.
BMC Public Health|May 12, 2012
Prevalence and determinants of chronic kidney disease in community-dwelling elderly by various estimating equationsDietrich Rothenbacher, Jochen Klenk, Michael Denkinger, et al.
Pageof 12